
Can small doses of GLP-1 medications do more than just support weight loss? In this episode, Dr. Nick explores the growing research behind microdosing semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound)—and how these powerful peptides may help reduce inflammation, improve heart health, support brain chemistry, and even play a role in overcoming addiction.
You’ll learn what makes microdosing different from traditional protocols, how it may optimize metabolic health without major side effects, and what early evidence suggests about the future of GLP-1 therapy beyond weight management.
🔗 Learn more: